| Vol. 23.08 – 14 March, 2022 |
| |
|
|
| Researchers investigated the role of the intestinal microbiome onvarious outcomes in a multicenter study of patients with B cell lymphoma and leukemia. [Nature Medicine] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Porcine and human stem cell-beta islets made insulin in xenotransplant models, and mouse islets tested in a marginal mass syngeneic transplant model cured diabetes in 92% of recipients within 24–48 hours after transplant. [Nature Medicine] |
|
|
|
| Scientists developed a dead-guide RNA-based CRISPR activation screen in primary CD8+ T cells and identified gain-of-function targets for CAR-T engineering. [Cell Metabolism] |
|
|
|
| The authors reported that induced pluripotent stem cellss reprogramed from CD62L+ naive and memory T cells followed by CD19-CAR engineering and 3D-organoid system differentiation conferred products with conventional CD8αβ-positive CAR T cell characteristics. [Cell Stem Cell] |
|
|
|
| Investigators extracted and identified primary MSCs and verified the promoting effects of tumor-associated mesenchymal stem cells on colorectal cancer (CRC) proliferation and metastasis in vivo and in vitro. [Molecular Therapy] |
|
|
|
| Scientists found that curcumin primed adipose tissue-derived mesenchymal stem cell-derived small extracellular vesicles (ADMSCs-sEVs) exhibited an enhanced protective effect compared with free curcumin and ADMSCs-sEV in TBHP-induced chondrocytes. [Journal of Nanobiotechnology] |
|
|
|
| Researchers studied the functions of umbilical cord mesenchymal stem cells-released Evs and their implicated molecules in mesangial proliferative glomerulonephritis. [Cell Communication and Signaling] |
|
|
|
| Clinical hepatocyte transplantation (HT) is only performed without general anesthesia, while inhalation anesthetics are usually used in animal experiments. The authors suggest that isoflurane may be a possible reason for the discrepancy between the results of animal experiments and the clinical outcomes of HTx. [Scientific Reports] |
|
|
|
| Stem cells from rat kidney were separated, and the surface stem cell markers were determined by flow cytometry analysis. [Environmental Science and Pollution Research] |
| |
|
|
|
| Scientists discuss the pertinent cardiovascular risks of the growing field of CAR-T cell therapy for today’s cardiologists, including incidence, characteristics, and treatment options, and conclude with an integrated management algorithm. [European Heart Journal] |
|
|
|
| The authors provided a comprehensive assessment of the short and long-term safety of hematopoietic stem and progenitor cells-gene therapy from trials using different vector platforms. [Nature Communications] |
|
|
|
|
| Cellevolve Bio and Seattle Children’s Therapeutics announced a collaboration aimed at developing and commercializing a suite of novel multiplex chimeric antigen receptors for the treatment of pediatric CNS malignancies. [Cellevolve Bio (Business Wire, Inc.)] |
|
|
|
| Abeona Therapeutics, Inc. announced that target enrollment has been achieved in its pivotal Phase III VIITAL™ study. The objective of VIITAL™ is to evaluate the safety and effectiveness of Abeona’s investigational EB-101 product for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). [Abeona Therapeutics Inc.] |
|
|
|
|
| April 6 – 9, 2022 Heidelberg, Germany |
|
|
|
|
|
| Aspect Biosystems – Vancouver, British Columbia, Canada |
|
|
|
| Institute of Cancer Research – London, England, United Kingdom |
|
|
|
| BioNTech – Gaithersburg, Maryland, United States |
|
|
|
| Friedrich Miescher Institute for Biomedical Research – Basel, Switzerland |
|
|
|
| Singapore-MIT Alliance for Research and Technology (SMART) Centre – Singapore, Singapore |
|
|
|
|